Cryoport, Inc. (NASDAQ:CYRX) Shares Sold by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P decreased its position in Cryoport, Inc. (NASDAQ:CYRX) by 0.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 765,561 shares of the consumer goods maker’s stock after selling 2,351 shares during the quarter. Loomis Sayles & Co. L P owned 1.68% of Cryoport worth $39,817,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Arkadios Wealth Advisors acquired a new stake in Cryoport during the first quarter worth approximately $26,000. FORA Capital LLC acquired a new stake in Cryoport during the first quarter worth approximately $35,000. Steward Partners Investment Advisory LLC raised its holdings in Cryoport by 655.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 755 shares of the consumer goods maker’s stock worth $33,000 after purchasing an additional 655 shares in the last quarter. Sowell Financial Services LLC raised its holdings in Cryoport by 1,907.3% during the first quarter. Sowell Financial Services LLC now owns 823 shares of the consumer goods maker’s stock worth $51,000 after purchasing an additional 782 shares in the last quarter. Finally, Captrust Financial Advisors acquired a new stake in Cryoport during the fourth quarter worth approximately $48,000. 89.06% of the stock is currently owned by institutional investors.

A number of research firms have weighed in on CYRX. Zacks Investment Research raised shares of Cryoport from a “hold” rating to a “buy” rating and set a $68.00 price objective on the stock in a report on Wednesday, July 7th. BTIG Research started coverage on shares of Cryoport in a report on Friday, July 16th. They set a “buy” rating and a $80.00 price objective on the stock. Finally, Needham & Company LLC lifted their target price on shares of Cryoport from $73.00 to $77.00 and gave the company a “buy” rating in a report on Wednesday, May 5th. Nine equities research analysts have rated the stock with a buy rating, Cryoport presently has a consensus rating of “Buy” and an average price target of $72.89.

In other Cryoport news, Director Daniel M. Hancock sold 10,000 shares of the business’s stock in a transaction on Monday, June 7th. The shares were sold at an average price of $60.02, for a total transaction of $600,200.00. Following the sale, the director now directly owns 14,627 shares in the company, valued at approximately $877,912.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Freeze Parent L.P. Blackstone sold 500,000 shares of the business’s stock in a transaction on Wednesday, June 9th. The stock was sold at an average price of $60.00, for a total transaction of $30,000,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 796,760 shares of company stock worth $47,611,256. 10.90% of the stock is currently owned by insiders.

NASDAQ:CYRX opened at $58.57 on Thursday. The firm has a fifty day moving average price of $58.29. Cryoport, Inc. has a 1-year low of $30.64 and a 1-year high of $84.97. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.78 and a current ratio of 11.08.

Cryoport (NASDAQ:CYRX) last posted its quarterly earnings data on Tuesday, May 4th. The consumer goods maker reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. Cryoport had a negative net margin of 26.41% and a positive return on equity of 3.17%. The firm had revenue of $53.30 million for the quarter, compared to analyst estimates of $46.78 million. During the same period last year, the firm posted ($0.11) EPS. Cryoport’s quarterly revenue was up 443.9% on a year-over-year basis. Analysts forecast that Cryoport, Inc. will post -0.49 earnings per share for the current fiscal year.

Cryoport Company Profile

Cryoport, Inc, a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities are maintained throughout the shipping cycle; and Cryoport Express Advanced Therapy Shippers that provides verification processes to biopharma companies.

Featured Article: Technical Analysis of Stocks and What It Means

Institutional Ownership by Quarter for Cryoport (NASDAQ:CYRX)

Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.